Bruker Corporation (BRKR)
NASDAQ: BRKR
· Real-Time Price · USD
33.31
0.53 (1.62%)
At close: Sep 23, 2025, 3:59 PM
1.62% (1D)
Bid | 33.23 |
Market Cap | 5.05B |
Revenue (ttm) | 3.44B |
Net Income (ttm) | 79.6M |
EPS (ttm) | 0.52 |
PE Ratio (ttm) | 64.06 |
Forward PE | 14.13 |
Analyst | Hold |
Dividends | $0.2 |
Ask | 33.37 |
Volume | 2,841,452 |
Avg. Volume (20D) | 4,084,326.1 |
Open | 33.00 |
Previous Close | 32.78 |
Day's Range | 32.93 - 34.15 |
52-Week Range | 28.53 - 72.94 |
Beta | 1.21 |
Ex-Dividend Date | Sep 23, 2025 |
About BRKR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BRKR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BRKR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBruker Corporation is scheduled to release its earnings on
Nov 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-11.68%
Bruker shares are trading lower after the company ...
Unlock content with
Pro Subscription
3 weeks ago
-2.21%
Bruker shares are trading lower after the company announced a $600 million public offering.

2 weeks ago · seekingalpha.com
BRUKP: Bruker Corp 6.375% Mandatory Convertible Preferred Stock IPOBruker Corporation 6.375 PREF SER A is a new 6.375% mandatory convertible preferred stock from Bruker, offering fixed income but closely tied to BRKR's common stock performance. Bruker's fundamentals ...

1 month ago · seekingalpha.com
Bruker: Former Academia Customer Strength, Now Incredible WeaknessBruker faces significant headwinds due to NIH funding cuts, heavy reliance on academia, and declining financial performance versus peers. Despite operational challenges and a sharp drop in valuation, ...